Quality of Life in Patients With Bladder Cancer
Running, not enrolling
Conditions studied: Bladder Cancer
In brief
The purpose of this study is to learn about the quality of life of people living with bladder cancer. We are interested in learning about how the treatments for bladder cancer affect people. We plan to use the findings from this study to help doctors provide better care and information to patients with bladder cancer.
Key facts
- Study ID
- NCT00745355
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 550
- Starts
- 2008-08-01
- Expected to finish
- 2026-08-01
- Last updated by the study team
- 2026-06-02
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients (male and female) who are diagnosed with bladder cancer
- Patients must be scheduled for radical cystectomy and urinary diversion are and/or being evaluated for neo-adjuvant chemotherapy prior to a planned cystectomy.
- Participants must be able to speak English.
- Participants must be able to provide informed consent.
- Participants must be 18 years of age or older to enroll.
- Participant may be eligible for and may receive neoadjuvant or adjuvant chemotherapy.
- Participant may have had intravesicle chemotherapy or immunotherapy (BCG, Interferon).
You may not qualify if…
- Subjects may be excluded from the study based on the following criteria:
- Follow-up care not obtained at MSKCC.
- Metastatic disease at diagnosis.
Where it is running
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.